These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34374741)

  • 1. Oral antithrombotic therapy for the prevention of recurrent cerebrovascular events.
    Capodanno D; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):383-391. PubMed ID: 34374741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack.
    Scalia L; Calderone D; Capodanno D
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1027-1038. PubMed ID: 36031827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
    Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
    Shah J; Liu S; Yu W
    Stroke Vasc Neurol; 2022 Oct; 7(5):406-414. PubMed ID: 35393359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis.
    Yang Y; Zhou M; Zhong X; Wang Y; Zhao X; Liu L; Wang Y
    Stroke Vasc Neurol; 2018 Jun; 3(2):107-116. PubMed ID: 30022798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack.
    Sandercock P; Mielke O; Liu M; Counsell C
    Cochrane Database Syst Rev; 2003; (1):CD000248. PubMed ID: 12535394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of a pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack: study protocol.
    Boehme C; Domig L; Komarek S; Toell T; Mayer L; Dejakum B; Krebs S; Pechlaner R; Bernegger A; Mueller C; Rumpold G; Griesmacher A; Vigl M; Schoenherr G; Schmidauer C; Ferrari J; Lang W; Knoflach M; Kiechl S
    BMC Cardiovasc Disord; 2022 Aug; 22(1):347. PubMed ID: 35915405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events.
    Hankey GJ; Eikelboom JW
    Lancet Neurol; 2010 Mar; 9(3):273-84. PubMed ID: 20170841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack.
    Zhang L; Shi J; Pan Y; Li Z; Yan H; Liu C; Lv W; Meng X; Wang Y
    Stroke Vasc Neurol; 2021 Sep; 6(3):376-383. PubMed ID: 33526631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.
    Sandercock P; Lindley R; Wardlaw J
    Br J Hosp Med; 1992 May 20-Jun 2; 47(10):731-7. PubMed ID: 1606457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis.
    Wong KS; Wang Y; Leng X; Mao C; Tang J; Bath PM; Markus HS; Gorelick PB; Liu L; Lin W; Wang Y
    Circulation; 2013 Oct; 128(15):1656-66. PubMed ID: 24030500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.
    McCabe DJ; Rakhit RD
    J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):14-24. PubMed ID: 17172564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic treatment of cerebrovascular disease.
    Oczkowski WJ; Turpie AG
    Baillieres Clin Haematol; 1990 Jul; 3(3):781-813. PubMed ID: 2271790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.
    Li L; Yiin GS; Geraghty OC; Schulz UG; Kuker W; Mehta Z; Rothwell PM;
    Lancet Neurol; 2015 Sep; 14(9):903-913. PubMed ID: 26227434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on antithrombotic secondary prevention of ischemic stroke].
    Köhrmann M; Kleinschnitz C
    Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention by stroke subtype: a nationwide follow-up study in 46 108 patients after acute ischaemic stroke.
    Kim D; Lee SH; Joon Kim B; Jung KH; Yu KH; Lee BC; Roh JK;
    Eur Heart J; 2013 Sep; 34(35):2760-7. PubMed ID: 23729692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.